XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Rights Offering
Private Placement
Series A Preferred Stock
Common Stock
Common Stock
Rights Offering
Common Stock
Private Placement
Treasury Stock
Additional Paid-in Capital
Additional Paid-in Capital
Rights Offering
Additional Paid-in Capital
Private Placement
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Shares outstanding at beginning of period (in shares) at Dec. 31, 2022       50,000 47,037,699                
Stockholders' equity at beginning of period at Dec. 31, 2022 $ 155,252       $ 5     $ (4,445) $ 617,233     $ (24,145) $ (433,396)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of common stock (in shares)           19,561,050 6,357,341            
Issuance of common stock   $ 47,602 $ 13,890     $ 2       $ 47,600 $ 13,890    
Exchange of mandatorily redeemable preferred shares (in shares)       (50,000)                  
Shares issued in connection with equity incentive plans (in shares)         837,848                
Shares issued pursuant to a license, services and collaboration agreement (in shares)         3,312                
Stock-based compensation expense and vesting of restricted stock units 9,557               9,557        
Other comprehensive income (loss) (1,968)                     (1,968)  
Net loss (169,495)                       (169,495)
Shares outstanding at end of period (in shares) at Jun. 30, 2023       0 73,797,250                
Total stockholders' equity at end of period at Jun. 30, 2023 54,838       $ 7     (4,445) 688,280     (26,113) (602,891)
Shares outstanding at beginning of period (in shares) at Mar. 31, 2023       50,000 73,174,547                
Stockholders' equity at beginning of period at Mar. 31, 2023 183,288       $ 7     (4,445) 684,643     (25,841) (471,076)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Exchange of mandatorily redeemable preferred shares (in shares)       (50,000)                  
Shares issued in connection with equity incentive plans (in shares)         622,703                
Stock-based compensation expense and vesting of restricted stock units 3,637               3,637        
Other comprehensive income (loss) (272)                     (272)  
Net loss (131,815)                       (131,815)
Shares outstanding at end of period (in shares) at Jun. 30, 2023       0 73,797,250                
Total stockholders' equity at end of period at Jun. 30, 2023 54,838       $ 7     (4,445) 688,280     (26,113) (602,891)
Shares outstanding at beginning of period (in shares) at Dec. 31, 2023       0 72,533,754                
Stockholders' equity at beginning of period at Dec. 31, 2023 45,893       $ 7     (5,445) 690,055     (24,910) (613,814)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Shares issued in connection with equity incentive plans (in shares)         720,091                
Stock-based compensation expense and vesting of restricted stock units 3,839               3,839        
Other (63)                       (63)
Other comprehensive income (loss) (885)                     (885)  
Net loss (33,099)                       (33,099)
Shares outstanding at end of period (in shares) at Jun. 30, 2024       0 73,253,845                
Total stockholders' equity at end of period at Jun. 30, 2024 15,685       $ 7     (5,445) 693,894     (25,795) (646,976)
Shares outstanding at beginning of period (in shares) at Mar. 31, 2024       0 72,643,445                
Stockholders' equity at beginning of period at Mar. 31, 2024 29,547       $ 7     (5,445) 691,889     (26,643) (630,261)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Shares issued in connection with equity incentive plans (in shares)         610,400                
Stock-based compensation expense and vesting of restricted stock units 2,005               2,005        
Other (63)                       (63)
Other comprehensive income (loss) 848                     848  
Net loss (16,652)                       (16,652)
Shares outstanding at end of period (in shares) at Jun. 30, 2024       0 73,253,845                
Total stockholders' equity at end of period at Jun. 30, 2024 $ 15,685       $ 7     $ (5,445) $ 693,894     $ (25,795) $ (646,976)